BeOne Medicines
Faisal AlSamran currently serves as the Director of Regulatory Affairs for MENA and Saudi Arabia at BeiGene since April 2023. Previously, Faisal was involved with RPCC as a member, contributing to regulatory and compliance working groups from August 2021 to March 2023. At Gilead Sciences, from December 2020 to March 2023, Faisal held the position of Director for Technical Scientific Office and Government Affairs, focusing on entity startup and licensing. Faisal's extensive background includes leadership roles at Roche, where responsibilities spanned quality assurance, regulatory affairs, and scientific affairs from April 2012 to March 2020. Early career experiences included positions at King Fahad Medical City and the Royal Commission for Jubail and Yanbu, along with regulatory and marketing management at Annahdah Medical Company. Faisal holds a Bachelor's degree in Pharmaceuticals from King Saud University.
This person is not in any teams
This person is not in any offices
BeOne Medicines
36 followers
BeOne Medicines is a global oncology company domiciled in Switzerland that is discovering and developing innovative treatments that are more affordable and accessible to cancer patients worldwide. With a portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. With a growing global team of more than 11,000 colleagues spanning six continents, the Company is committed to radically improving access to medicines for far more patients who need them.